Use of factor VIIa factor for treating trauma

Details for Australian Patent Application No. 2005210176 (hide)

Owner Novo Nordisk Health Care AG

Inventors Skolnick, Brett E.; Axelsen, Mads; Erhardtsen, Elisabeth

Agent Shelston IP

Pub. Number AU-A-2005210176

PCT Pub. Number WO2005/074975

Priority PA 2004 01239 16.08.04 DK; PA 2004 00178 05.02.04 DK; PA 2004 00341 01.03.04 DK; PA 2004 00339 01.03.04 DK; PA 2004 01553 08.10.04 DK; PA 2004 01552 08.10.04 DK; PA 2004 01240 16.08.04 DK

Filing date 4 February 2005

Wipo publication date 18 August 2005

International Classifications

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/074975 Priority application(s): WO2005/074975

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210181-Composition, comprising L-serine, Lisoleucine, folic acid and trace elements, for treating psoriasis

2005210175-Use of factor VIIa for treating late complications of trauma